AlphaQuest LLC Increases Stock Holdings in Encompass Health Co. (NYSE:EHC)

AlphaQuest LLC grew its position in Encompass Health Co. (NYSE:EHC - Free Report) by 216.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,700 shares of the company's stock after buying an additional 19,633 shares during the quarter. Encompass Health accounts for 0.4% of AlphaQuest LLC's holdings, making the stock its 23rd largest holding. AlphaQuest LLC's holdings in Encompass Health were worth $2,650,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Raymond James Financial Inc. purchased a new stake in Encompass Health during the fourth quarter worth about $77,944,000. Point72 Asset Management L.P. increased its stake in Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock worth $83,990,000 after buying an additional 835,135 shares during the period. Jennison Associates LLC acquired a new stake in Encompass Health during the 4th quarter worth approximately $52,094,000. abrdn plc purchased a new position in Encompass Health in the 4th quarter valued at approximately $17,846,000. Finally, Thrivent Financial for Lutherans grew its stake in shares of Encompass Health by 26.0% in the third quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company's stock worth $73,494,000 after acquiring an additional 156,938 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Stock Performance

Shares of Encompass Health stock traded down $0.71 on Thursday, hitting $93.57. The stock had a trading volume of 836,587 shares, compared to its average volume of 637,145. The company's 50 day moving average price is $97.22 and its 200 day moving average price is $96.88. The stock has a market cap of $9.42 billion, a price-to-earnings ratio of 20.98, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52-week low of $74.27 and a 52-week high of $104.55.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.73%. The ex-dividend date is Tuesday, April 1st. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

Analysts Set New Price Targets

Several research firms recently commented on EHC. Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. KeyCorp boosted their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. William Blair restated an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, Encompass Health currently has an average rating of "Buy" and an average target price of $107.67.

Insider Buying and Selling at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the business's stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.10% of the stock is owned by company insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.